DUBLIN, Nov. 19, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/jtj4nx/2016_u_s) has announced the addition of the "2016 U.S. Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Instrument and Reagent Supplier Shares, Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies" report to their offering.
Rationale
During the next five years, the US blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology.
Strategic Recommendations
The report explores future marketing and technological trends in the US; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next ten years.
Companies Mentioned
Sales and Market Share Analysis
Sales and market share estimates of leading suppliers of blood banking of reagents and instruments, by individual product.
Market Segmentation Analysis
Current and Emerging Products
For more information visit http://www.researchandmarkets.com/research/jtj4nx/2016_u_s
Media Contact:
Laura Wood, +353-1-481-1716, [email protected]
SOURCE Research and Markets
Share this article